Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 16-Oct-24 4:12 PM View:  | Freeman Kevin D Director | Pro-Pharmaceuticals Inc. (GALT) | 16-Oct-24 | Purchase | 5,000 | $2.70 | $13,500.00 | 4% 126.53K to 131.53K | |
| 16-Oct-24 4:12 PM View: | Freeman Kevin D Director | Pro-Pharmaceuticals Inc. (GALT) | 16-Oct-24 | Purchase | 5,000 | $2.70 | $13,500.00 | 4% 121.53K to 126.53K | |
| 26-Aug-24 8:08 AM View: | Zordani Richard A. Jr. Director | Pro-Pharmaceuticals Inc. (GALT) | 23-Aug-24 | Market Purchase | 1,000 | $2.30 | $2,300.00 | 3% 31.32K to 32.32K | (8%) |
| 26-Aug-24 8:08 AM View: | Zordani Richard A. Jr. Director | Pro-Pharmaceuticals Inc. (GALT) | 23-Aug-24 | Market Purchase | 1,759 | $2.30 | $4,045.70 | 5% 32.32K to 34.08K | (8%) |
| 26-Aug-24 8:08 AM View: | Zordani Richard A. Jr. Director | Pro-Pharmaceuticals Inc. (GALT) | 22-Aug-24 | Market Purchase | 741 | $2.30 | $1,704.30 | 2% 30.58K to 31.32K | (8%) |
| 20-Jun-24 1:55 PM View: | Freeman Kevin D Director | Pro-Pharmaceuticals Inc. (GALT) | 20-Jun-24 | Purchase | 2,500 | $2.38 | $5,949.75 | 2% 119.03K to 121.53K | |
| 30-Apr-24 2:14 PM View: | Zordani Richard A. Jr. Director | Pro-Pharmaceuticals Inc. (GALT) | 30-Apr-24 | Purchase | 1,000 | $3.52 | $3,520.00 | 3% 29.58K to 30.58K | |
| 25-Apr-24 1:27 PM View: | Lewis Joel President and CEO Director | Pro-Pharmaceuticals Inc. (GALT) | 24-Apr-24 | Purchase | 1,000 | $3.39 | $3,390.00 | < 1% 898.01K to 899.01K | |
| 25-Apr-24 11:36 AM View: | Czirr James C 10% Owner | Pro-Pharmaceuticals Inc. (GALT) | 23-Apr-24 | Sale | 3,677 | $3.06 | $11,251.60 | (< 1%) 5.93M to 5.92M | |
| 22-Apr-24 4:04 PM View: | Freeman Kevin D Director | Pro-Pharmaceuticals Inc. (GALT) | 22-Apr-24 | Purchase | 2,500 | $2.98 | $7,450.00 | 2% 116.53K to 119.03K | |
| 25-Apr-24 11:36 AM View: | Czirr James C 10% Owner | Pro-Pharmaceuticals Inc. (GALT) | 22-Apr-24 | Private Sale | 21,323 | $3.06 | $65,248.40 | (< 1%) 5.95M to 5.93M | |
| 09-Apr-24 4:42 PM View: | Freeman Kevin D Director | Pro-Pharmaceuticals Inc. (GALT) | 09-Apr-24 | txn.W.title | 2,063 | -- | -- | 2% 114.47K to 116.53K | |
| 04-Mar-24 12:50 PM View: | Lewis Joel President and CEO Director | Pro-Pharmaceuticals Inc. (GALT) | 01-Mar-24 | Grant | 152,584 | $1.96 | $299,065.00 | (15%) 1.05M to 897.72K | (8%) |
| 07-Feb-24 4:53 PM View: | Uihlein Richard E Director 10% Owner | Pro-Pharmaceuticals Inc. (GALT) | 24-Jan-24 | Grant | 23,256 | $1.72 | $40,000.30 | < 1% 10.27M to 10.3M | |
| 23-Jul-24 9:38 AM View: | Eldred Kary Director | Pro-Pharmaceuticals Inc. (GALT) | 16-Jan-24 | Purchase | 400 | $2.39 | $956.00 | < 1% 53.74K to 54.14K | |
| 16-Jan-24 11:23 AM View: | Eldred Kary Director | Pro-Pharmaceuticals Inc. (GALT) | 16-Jan-24 | Private Purchase | 500 | $1.79 | $892.90 | < 1% 53.24K to 53.74K | |
| 02-Jan-24 8:07 AM View: | Lewis Joel President and CEO Director | Pro-Pharmaceuticals Inc. (GALT) | 29-Dec-23 | Grant | 11,606 | $1.66 | $19,266.00 | 1% 1.03M to 1.04M | |
| 18-Dec-23 8:41 AM View: | Lewis Joel President and CEO Director | Pro-Pharmaceuticals Inc. (GALT) | 15-Dec-23 | Grant | 12,042 | $1.60 | $19,267.20 | 1% 1.02M to 1.03M | |
| 01-Dec-23 8:05 AM View: | Lewis Joel President and CEO Director | Pro-Pharmaceuticals Inc. (GALT) | 30-Nov-23 | Grant | 9,880 | $1.95 | $19,266.00 | < 1% 1.01M to 1.02M | 9% |
| 15-Nov-23 5:19 PM View: | Lewis Joel President and CEO Director | Pro-Pharmaceuticals Inc. (GALT) | 15-Nov-23 | Grant | 10,303 | $1.87 | $19,266.60 | 1% 998.47K to 1.01M | |
| 31-Oct-23 4:03 PM View: | Lewis Joel President and CEO Director | Pro-Pharmaceuticals Inc. (GALT) | 31-Oct-23 | Grant | 9,444 | $2.04 | $19,265.80 | < 1% 989.02K to 998.47K | 4% |
| 16-Oct-23 8:09 AM View: | Lewis Joel President and CEO Director | Pro-Pharmaceuticals Inc. (GALT) | 13-Oct-23 | Grant | 10,035 | $2.01 | $20,170.30 | 1% 978.99K to 989.02K | 5% |
| 25-Apr-24 10:00 PM View: | Czirr James C 10% Owner | Pro-Pharmaceuticals Inc. (GALT) | 30-Sep-23 | Acquisition (other) | 1,000 | $6.00 | $6,000.00 | < 1% 761.62K to 762.62K | |
| 02-Oct-23 7:43 AM View: | Lewis Joel President and CEO Director | Pro-Pharmaceuticals Inc. (GALT) | 29-Sep-23 | Grant | 10,035 | $1.92 | $19,267.20 | 1% 969.4K to 979.44K | 10% |
| 27-Sep-23 2:03 PM View: | Uihlein Richard E Director 10% Owner | Pro-Pharmaceuticals Inc. (GALT) | 26-Sep-23 | Option Exercise | 2,236,200 | $4.49 | $10,033,000.00 | 28% 8.03M to 10.26M | |
| 18-Sep-23 9:53 AM View: | Lewis Joel President and CEO Director | Pro-Pharmaceuticals Inc. (GALT) | 15-Sep-23 | Grant | 10,947 | $1.76 | $19,266.70 | 1% 958.46K to 969.4K | |
| 01-Sep-23 7:16 AM View: | Lewis Joel President and CEO Director | Pro-Pharmaceuticals Inc. (GALT) | 31-Aug-23 | Grant | 11,010 | $1.75 | $19,267.50 | 1% 947.45K to 958.46K | |
| 15-Aug-23 4:05 PM View: | Lewis Joel President and CEO Director | Pro-Pharmaceuticals Inc. (GALT) | 15-Aug-23 | Grant | 12,042 | $1.60 | $19,267.20 | 1% 935.41K to 947.45K | |
| 31-Jul-23 4:14 PM View: | Lewis Joel President and CEO Director | Pro-Pharmaceuticals Inc. (GALT) | 31-Jul-23 | Grant | 12,844 | $1.50 | $19,266.00 | 1% 922.56K to 935.41K | |
| 20-Jul-23 7:40 AM View: | Eldred Kary Director | Pro-Pharmaceuticals Inc. (GALT) | 19-Jul-23 | Private Purchase | 1,598 | $1.79 | $2,854.03 | 3% 51.64K to 53.24K | |
| 17-Jul-23 8:02 AM View: | Lewis Joel President and CEO Director | Pro-Pharmaceuticals Inc. (GALT) | 14-Jul-23 | Grant | 11,820 | $1.63 | $19,266.60 | 1% 910.74K to 922.56K | |
| 16-Jun-23 7:50 AM View: | Lewis Joel President and CEO Director | Pro-Pharmaceuticals Inc. (GALT) | 15-Jun-23 | Grant | 13,196 | $1.46 | $19,266.20 | 1% 884.17K to 897.36K | |
| 01-Jun-23 7:53 AM View: | Lewis Joel President and CEO Director | Pro-Pharmaceuticals Inc. (GALT) | 31-May-23 | Grant | 12,272 | $1.57 | $19,267.00 | 1% 871.89K to 884.17K | |
| 16-May-23 7:47 AM View: | Lewis Joel President and CEO Director | Pro-Pharmaceuticals Inc. (GALT) | 15-May-23 | Grant | 11,748 | $1.64 | $19,266.70 | 1% 860.15K to 871.89K | |
| 09-May-23 9:42 AM View: | Lewis Joel President and CEO Director | Pro-Pharmaceuticals Inc. (GALT) | 28-Apr-23 | Grant | 10,947 | $1.76 | $19,266.70 | 1% 849.2K to 860.15K | |
| 17-Apr-23 7:59 AM View: | Lewis Joel President and CEO Director | Pro-Pharmaceuticals Inc. (GALT) | 14-Apr-23 | Grant | 9,585 | $2.01 | $19,265.80 | 1% 839.61K to 849.2K | 5% |
| 25-Apr-24 10:00 PM View: | Czirr James C 10% Owner | Pro-Pharmaceuticals Inc. (GALT) | 31-Mar-23 | Acquisition (other) | 1,000 | $6.00 | $6,000.00 | < 1% 760.62K to 761.62K | |
| 03-Apr-23 8:29 AM View: | Lewis Joel President and CEO Director | Pro-Pharmaceuticals Inc. (GALT) | 31-Mar-23 | Grant | 9,175 | $2.10 | $19,267.50 | 1% 830.44K to 839.61K | < 1% |
| 16-Mar-23 10:00 PM View: | Lewis Joel President and CEO Director | Pro-Pharmaceuticals Inc. (GALT) | 15-Mar-23 | Grant | 10,140 | $1.90 | $19,266.00 | 1% 820.3K to 830.44K | |
| 02-Mar-23 7:48 AM View: | Lewis Joel President and CEO Director | Pro-Pharmaceuticals Inc. (GALT) | 01-Mar-23 | Payment of Exercise | 75,529 | $2.07 | $156,345.00 | (8%) 895.83K to 820.3K | (2%) |
| 02-Mar-23 7:48 AM View: | Lewis Joel President and CEO Director | Pro-Pharmaceuticals Inc. (GALT) | 28-Feb-23 | Grant | 9,308 | $2.07 | $19,267.60 | 1% 886.52K to 895.83K | 2% |
| 21-Feb-23 12:16 PM View: | Eldred Kary Director | Pro-Pharmaceuticals Inc. (GALT) | 21-Feb-23 | Private Purchase | 1,000 | $1.59 | $1,591.10 | 2% 50.64K to 51.64K | |
| 21-Feb-23 8:31 AM View: | Lewis Joel President and CEO Director | Pro-Pharmaceuticals Inc. (GALT) | 16-Feb-23 | Private Purchase | 1,000 | $1.52 | $1,520.00 | < 1% 886.52K to 887.52K | |
| 15-Feb-23 4:06 PM View: | Lewis Joel President and CEO Director | Pro-Pharmaceuticals Inc. (GALT) | 15-Feb-23 | Grant | 13,380 | $1.44 | $19,267.20 | 2% 873.14K to 886.52K | |
| 07-Feb-23 7:43 AM View: | Lewis Joel President and CEO Director | Pro-Pharmaceuticals Inc. (GALT) | 07-Feb-23 | Grant | 143,836 | $1.43 | $205,685.00 | 20% 729.3K to 873.14K | |
| 31-Jan-23 4:03 PM View: | Lewis Joel President and CEO Director | Pro-Pharmaceuticals Inc. (GALT) | 31-Jan-23 | Grant | 15,086 | $1.16 | $17,499.80 | 2% 714.22K to 729.3K | |
| 30-Jan-23 4:34 PM View: | Uihlein Richard E Director 10% Owner | Pro-Pharmaceuticals Inc. (GALT) | 26-Jan-23 | Grant | 36,036 | $1.11 | $40,000.00 | < 1% 7.99M to 8.03M | |
| 26-Jan-23 7:44 AM View: | Eldred Kary Director | Pro-Pharmaceuticals Inc. (GALT) | 25-Jan-23 | Private Purchase | 1,300 | $1.11 | $1,443.00 | 3% 49.34K to 50.64K | |
| 17-Jan-23 7:51 AM View: | Lewis Joel President and CEO Director | Pro-Pharmaceuticals Inc. (GALT) | 13-Jan-23 | Grant | 15,351 | $1.14 | $17,500.10 | 2% 698.87K to 714.22K | |
| 03-Jan-23 8:13 AM View: | Lewis Joel President and CEO Director | Pro-Pharmaceuticals Inc. (GALT) | 30-Dec-22 | Grant | 15,487 | $1.13 | $17,500.30 | 2% 683.38K to 698.87K |
